[{"orgOrder":0,"company":"Ever Pharma","sponsor":"Ever Pharma","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"","productType":"Undisclosed","year":"2020","type":"Inapplicable","leadProduct":"Cerebrolysin","moa":"Neurotrophic factor","graph1":"Neurology","graph2":"Phase IV","graph3":"Ever Pharma","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Intravenous","sponsorNew":"Ever Pharma \/ Ever Pharma","highestDevelopmentStatusID":"11","companyTruncated":"Ever Pharma \/ Ever Pharma"},{"orgOrder":0,"company":"Ever Pharma","sponsor":"idv Datenanalyse & Versuchsplanung | XClinical GmbH","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"AUSTRIA","productType":"Undisclosed","year":"2023","type":"Inapplicable","leadProduct":"Cerebrolysin","moa":"Neurotrophic factor","graph1":"Neurology","graph2":"Phase II","graph3":"Ever Pharma","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Ever Pharma \/ idv Datenanalyse & Versuchsplanung | XClinical GmbH","highestDevelopmentStatusID":"8","companyTruncated":"Ever Pharma \/ idv Datenanalyse & Versuchsplanung | XClinical GmbH"}]

Find Neurology Clinical Drug Pipeline Developments & Deals by Ever Pharma

Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          Lead Product(s) : Cerebrolysin

                          Therapeutic Area : Neurology

                          Study Phase : Phase II

                          Sponsor : idv Datenanalyse & Versuchsplanung | XClinical GmbH

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Undisclosed

                          Upfront Cash : Inapplicable

                          March 06, 2023

                          Lead Product(s) : Cerebrolysin

                          Therapeutic Area : Neurology

                          Highest Development Status : Phase II

                          Sponsor : idv Datenanalyse & Versuchsplanung | XClinical GmbH

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Ever Pharma CB

                          02

                          Lead Product(s) : Cerebrolysin

                          Therapeutic Area : Neurology

                          Study Phase : Phase IV

                          Recipient : Konkuk University Medical Center

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Undisclosed

                          Upfront Cash : Inapplicable

                          June 11, 2020

                          Lead Product(s) : Cerebrolysin

                          Therapeutic Area : Neurology

                          Highest Development Status : Phase IV

                          Recipient : Konkuk University Medical Center

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Ever Pharma CB

                          03

                          Lead Product(s) : Cerebrolysin

                          Therapeutic Area : Neurology

                          Study Phase : Phase IV

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Undisclosed

                          Upfront Cash : Inapplicable

                          April 04, 2013

                          Lead Product(s) : Cerebrolysin

                          Therapeutic Area : Neurology

                          Highest Development Status : Phase IV

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Ever Pharma CB